Inquiry Basket
Loading ......
Filter By Product Search for
SPTAN1
SPTAN1 Full Name
spectrin, alpha, non-erythrocytic 1
SPTAN1 Introduction
SPTAN1 encodes a large cytoskeletal scaffold protein that is expressed ubiquitously throughout the nervous system. The gene is located on chromosome 9q34.11 and produces a protein of approximately 2,472 amino acids. Like other members of the spectrin superfamily, αII-spectrin contains an N-terminal actin-binding domain composed of two calponin homology (CH) subdomains, a central rod domain consisting of 20 triple-helical spectrin repeat units that form the characteristic coiled-coil bundles, and a C-terminal pleckstrin homology (PH) domain that mediates membrane association. In the nervous system, αII-spectrin forms obligate heterodimers with β-spectrins (predominantly βII- and βIV-spectrin), which then associate head-to-head to produce heterotetramers. These tetramers connect actin ring-like structures spaced approximately 190 nm apart along axons, forming the membrane-associated periodic skeleton (MPS) — a nanoscale lattice first visualized by super-resolution microscopy that provides mechanical resilience to axons and organizes membrane proteins along their surface.
Figure 1. Structure of SPTAN. (Source: Ackermann, et al. 2019)
At the axon initial segment (AIS) — the specialized proximal axonal domain responsible for action potential initiation — αII-spectrin works in concert with βIV-spectrin and the scaffolding protein ankyrin-G to cluster voltage-gated sodium channels (Nav1.2, Nav1.6) and establish a diffusion barrier between the axonal and somatodendritic compartments. This structural organization is critical for determining neuronal excitability and maintaining neuronal polarity. Loss of αII-spectrin disrupts AIS architecture, impairs sodium channel clustering, and compromises the diffusion barrier, rendering neurons functionally abnormal. Beyond the AIS, SPTAN1 is also found at nodes of Ranvier in myelinated axons, where it contributes to nodal channel organization and supports the long-term integrity of large-diameter myelinated fibers. Conditional deletion studies in mice have confirmed that αII-spectrin is indispensable for both axonal survival and proper brain development.
Pathogenic variants in SPTAN1 give rise to a clinically heterogeneous spectrum of neurological disorders. The most severe presentation, caused by heterozygous dominant-negative in-frame mutations that cluster in the C-terminal spectrin repeats, is West syndrome (also known as SPTAN1 epileptic encephalopathy), characterized by infantile spasms, hypsarrhythmia on EEG, severe intellectual disability, spastic quadriplegia, and diffuse cerebral hypomyelination. The dominant-negative mechanism is thought to involve abnormal αII/βII-spectrin aggregation that disrupts the entire AIS scaffold. De novo in-frame mutations have additionally been reported in patients with intellectual disability and pontocerebellar atrophy. At the milder end of the spectrum, heterozygous nonsense and missense variants in SPTAN1 have been identified in families with juvenile-onset hereditary motor neuropathy and axonal sensorimotor neuropathy, in which progressive distal muscle weakness and axonal degeneration are the predominant features. Most recently, dominant SPTAN1 variants have been linked to spastic paraplegia and cerebellar ataxia, further expanding the phenotypic landscape. Collectively, the broad SPTAN1 disease spectrum — ranging from devastating neonatal epileptic encephalopathy to adult-onset motor neuron disease — underscores the non-redundant and dose-sensitive roles of αII-spectrin across the entire nervous system throughout the human lifespan.
Alternate Names for SPTAN1
SPTAN1; spectrin, alpha, non-erythrocytic 1; SPECA; spectrin alpha chain, non-erythrocytic 1; alpha-spectrin; alpha-II spectrin; fodrin alpha chain; nonerythroid alpha-spectrin; spectrin alpha chain, brain; spectrin, non-erythroid alpha chain; spectrin, alpha, non-erythrocytic 1 (alpha-fodrin);
Loading ......
